97 related articles for article (PubMed ID: 8655220)
1. The production of platelet-activating factor (PAF) during hemodialysis with cuprophane membrane. Does the calcium concentration in the dialysate play any role on it?
Iatrou C; Afentakis N; Antonopoulou S; Andrikopoulos N; Demopoulos CA; Ziroyannis P
Int J Artif Organs; 1995 Jul; 18(7):355-61. PubMed ID: 8655220
[TBL] [Abstract][Full Text] [Related]
2. Is platelet-activating factor produced during hemodialysis with AN-69 polyacrylonitrile membrane?
Iatrou C; Afentakis N; Nomikos T; Dinas C; Stavropoulos-Giokas C; Antonopoulou S
Nephron; 2002 May; 91(1):86-93. PubMed ID: 12021524
[TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor production during hemodialysis: effect of BN 52021.
Cristol JP; Canaud B; Damon M; Chavis C; Arnoux B; Mion C
Prostaglandins Leukot Essent Fatty Acids; 1992 Jan; 45(1):37-42. PubMed ID: 1546065
[TBL] [Abstract][Full Text] [Related]
4. The role of PAF and leukotrienes in bioincompatibility of cuprophane membranes in hemodialysis.
Kabasakal C; Mir S; Gousseinov A; Cura A; Betin N; Coker I
Turk J Pediatr; 1998; 40(3):413-20. PubMed ID: 9763906
[TBL] [Abstract][Full Text] [Related]
5. Increases in circulating level of platelet-activating factor lag behind transient neutropenia during hemodialysis with cuprophane membranes.
Sakaguchi K; Morimoto S; Chen YH; Nakamoto Y; Ogihara T
Nephron; 1991; 59(3):455-60. PubMed ID: 1758537
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms and kinetics of the synthesis and release of platelet-activating factor (PAF) by polyacrylonitrile membranes.
Guastoni C; Tetta C; Hoenich NA; Gervasio R; Sereni L; Tessore E; Wratten ML; Civati G
Clin Nephrol; 1996 Aug; 46(2):132-8. PubMed ID: 8869791
[TBL] [Abstract][Full Text] [Related]
7. Endothelin and platelet activating factor. Possible indices for biocompatibility of hemodialysis.
Akizawa T; Kinugasa E; Koshikawa S
ASAIO Trans; 1991; 37(3):M384-5. PubMed ID: 1751199
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
Germin Petrović D
Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
[TBL] [Abstract][Full Text] [Related]
9. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
[TBL] [Abstract][Full Text] [Related]
10. [Changes in leukocyte counts using a cellulose acetate membrane (FB-T) during hemodialysis. A comparison with a cuprophane membrane].
Pak K; Kobira S; Tomoyoshi T; Nishimura N
Hinyokika Kiyo; 1986 Sep; 32(9):1231-5. PubMed ID: 3812143
[TBL] [Abstract][Full Text] [Related]
11. The production of platelet-activating factor during hemodialysis.
Tetta C; Segoloni G; Pacitti A; Regis G; Salomone M; Turello E; Camussi G; Vercellone A
Int J Artif Organs; 1989 Dec; 12(12):766-72. PubMed ID: 2613357
[TBL] [Abstract][Full Text] [Related]
12. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?
Mrowka C; Heintz B; Sieberth HG
Clin Nephrol; 1999 Nov; 52(5):312-21. PubMed ID: 10584995
[TBL] [Abstract][Full Text] [Related]
13. Studies of biocompatibility of different dialyzer membranes: role of complement system, intracellular calcium and inositol-triphosphate.
Haag-Weber M; Mai B; Deppisch R; Göhl H; Hörl WH
Clin Nephrol; 1994 Apr; 41(4):245-51. PubMed ID: 8026120
[TBL] [Abstract][Full Text] [Related]
14. Citrate anticoagulation does not correct cuprophane bioincompatibility as evaluated by the expression of leukocyte surface molecules.
Dhondt A; Vanholder R; Waterloos MA; Glorieux G; De Smet R; Lameire N
Nephrol Dial Transplant; 1998 Jul; 13(7):1752-8. PubMed ID: 9681723
[TBL] [Abstract][Full Text] [Related]
15. [Immediate effect of hemodialysis with cuprophane membrane and acetate containing dialysis fluid on respiratory function in patients with chronic renal failure].
Wanic-Kossowska M
Pol Tyg Lek; 1993 Feb 15-22; 48(7-8):175-7. PubMed ID: 8415262
[TBL] [Abstract][Full Text] [Related]
16. Role of complement and platelet-activating factor in the stimulation of phagocytosis and reactive oxygen species production during haemodialysis.
Gastaldello K; Husson C; Wens R; Vanherweghem JL; Tielemans C
Nephrol Dial Transplant; 2000 Oct; 15(10):1638-46. PubMed ID: 11007834
[TBL] [Abstract][Full Text] [Related]
17. Serum calcium increases the incidence of arrhythmias during acetate hemodialysis.
Nishimura M; Nakanishi T; Yasui A; Tsuji Y; Kunishige H; Hirabayashi M; Takahashi H; Yoshimura M
Am J Kidney Dis; 1992 Feb; 19(2):149-55. PubMed ID: 1739097
[TBL] [Abstract][Full Text] [Related]
18. Effect of dialyzer geometry during hemodialysis with cuprophane membranes.
Taylor JE; McLaren M; Mactier RA; Henderson IS; Stewart WK; Belch JJ
Kidney Int; 1992 Aug; 42(2):442-7. PubMed ID: 1405328
[TBL] [Abstract][Full Text] [Related]
19. [Concentrations of acute phase proteins in serum during the first two hours of hemodialysis using cuprophane and cellulose acetate dialyzers in patients with chronic renal failure].
Starzyk J; Bartelik S
Pol Arch Med Wewn; 1993 Aug; 90(2):127-33. PubMed ID: 7504251
[TBL] [Abstract][Full Text] [Related]
20. Role of platelet activating factor in hemodialysis.
Tetta C; David S; Biancone L; Canino F; Cambi V; Camussi G
Kidney Int Suppl; 1993 Jan; 39():S154-7. PubMed ID: 8468919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
